<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:media="http://search.yahoo.com/mrss/">
<channel>
    
        <item>
            <title>STUDY FINDS SARS-COV-2 EVADES OUR IMMUNE SYSTEM - The Daily Guardian</title>
            <link>https://latest.thedailyguardian.com/medically-speaking/study-finds-sars-cov-2-evades-our-immune-system/</link>
            <guid>https://latest.thedailyguardian.com/medically-speaking/study-finds-sars-cov-2-evades-our-immune-system/</guid>
            <pubDate>January 4, 2022, 9:50 am</pubDate>
            <description><![CDATA[Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I.
]]></description>
            <content:encoded><![CDATA[
<p>A new study has identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.</p>



<p>The research is published in the ‘Nature Communications Journal’. Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 infection takes hold.</p>



<p>“Our discovery reveals how the virus can evade the human immune defence system and might help to explain why the pandemic has been so severe,” said Hokkaido University and Texas A&amp;M University immunologist Koichi Kobayashi, who led the study.</p>



<p>“The mechanisms we identify may provide new molecular targets for drug discovery,” Kobayashi added.</p>



<p>The scientists used a bioinformatics approach to look at how SARS-CoV-2, the virus that causes COVID-19, changed gene expression in the immune systems of COVID-19 patients compared to uninfected individuals. This is a useful way to look into the function of complicated cell signalling pathways that trigger immune responses to fight off harmful bacteria and viruses.</p>



<p>MHC (major histocompatibility complex) class I molecules are a central weapon in the immune response against viruses. When a virus infects a cell, the cell facilitates the expression of viral antigens on the surface of infected cells, drawing the attention of immune cells called cytotoxic T cells. These immune cells zero in on and destroy the infected cells, together with the invading virus inside them.</p>



<p>In addition to analysing gene expression in COVID-19 patients, the research team also infected human cell lines with the SARS-CoV-2 virus to validate their findings.</p>



<p>The results showed that a protein from the SARS-CoV-2 virus, called ORF 6, suppressed a host cell protein, called NLRC5, responsible for activating the MHC class I pathway.</p>



<p>The study showed this happens in two ways. ORF6 hampered cell signalling, which turned off the expression of NLRC5. ORF6 also blocked the function of NLRC5.</p>



<p>Other infectious viruses, including HIV and MERS, are known to also target the MHC class I pathway. Researchers believed that SARS-CoV-2 probably did as well, but this study is the first to unravel the mechanism.</p>



<p>“Without the activation of the MHC class I pathway, viruses in the infected cells are essentially hidden from the immune system. That helps to explain why SARS-CoV-2 virus persists in the body and why it keeps infecting others, leading to the pandemic,” Kobayashi said. The research is published in the ‘ Nature Communications Journal’.</p>
]]></content:encoded>
            <media:content url="https://latest.thedailyguardian.com/wp-content/uploads/2022/01/ms.jpg" type="image/jpeg" width="1632" height="1045"/>
            <dc:creator>Correspondent</dc:creator>
            <category></category>
        </item>
</channel>
</rss>